Based on the key indicators related to Viatris' liquidity, profitability, solvency, and operating efficiency, Viatris may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Viatris' Cash is comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 41.9 B in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 622.1 M in 2025. Key indicators impacting Viatris' financial strength include:
The essential information of the day-to-day investment outlook for Viatris includes many different criteria found on its balance sheet. An individual investor should monitor Viatris' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Viatris.
Please note, the imprecision that can be found in Viatris' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Viatris. Check Viatris' Beneish M Score to see the likelihood of Viatris' management manipulating its earnings.
Viatris Stock Summary
Viatris competes with Bausch Health, Tilray, Takeda Pharmaceutical, Elanco Animal, and Zoetis. The company operates in four segments Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. Viatris operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 37000 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Viatris' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Viatris's current stock value. Our valuation model uses many indicators to compare Viatris value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Viatris competition to find correlations between indicators driving Viatris's intrinsic value. More Info.
Viatris is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Viatris' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Viatris by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Viatris Systematic Risk
Viatris' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Viatris volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Viatris correlated with the market. If Beta is less than 0 Viatris generally moves in the opposite direction as compared to the market. If Viatris Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Viatris is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Viatris is generally in the same direction as the market. If Beta > 1 Viatris moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Viatris Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Viatris' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Viatris growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Viatris help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Viatris. We use our internally-developed statistical techniques to arrive at the intrinsic value of Viatris based on widely used predictive technical indicators. In general, we focus on analyzing Viatris Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Viatris's daily price indicators and compare them against related drivers.
When running Viatris' price analysis, check to measure Viatris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viatris is operating at the current time. Most of Viatris' value examination focuses on studying past and present price action to predict the probability of Viatris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viatris' price. Additionally, you may evaluate how the addition of Viatris to your portfolios can decrease your overall portfolio volatility.